ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 693167 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 693167; 2) Community: the network communities that were significantly associated with the response to NSC 693167; 3) Molecule: the relationships between components within communities and NSC 693167; 4) MDR: the compounds that were significantly associated with the NSC 693167.

NSC Compound Enrichment Correlation
NSC 621322 Null 0.011544784012433 0.053096339
NSC 639174 Camptothecin Derivative 0.011544784012433 0.5012506
NSC 639186 Raltitrexed 0.011544784012433 0.52833889
NSC 644960 Null 0.011544784012433 0.58427616
NSC 659950 7-O-(3,4-Di-O-acetyl-2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.011544784012433 0.5809064
NSC 662123 Null 0.011544784012433 0.077020489
NSC 666220 Null 0.011544784012433 -0.0069640533
NSC 672073 Null 0.011544784012433 0.2176301
NSC 674347 4-(1,1-Dimethylethyl)-1-(1-methylethyl)-{9,10-dihydro-12-met hoxy-8-hydroxymethyl-9-oxoindolizo[1,2-b]quinolin-7-yl}butanedioate 0.011544784012433 0.62835961
NSC 681639 Camptothecin Derivative 0.011544784012433 0.57960346
Total:47  Current:16    [First] [Prev] [Next] [Last]